THE EFFECT OF AGMATINE ON SPIKE-AND-WAVE DISCHARGES IN A GENETIC MODEL OF ABSENCE EPILEPSY/AGMATININ GENETIK BIR ABSANS EPILEPSI MODELINDE DIKEN-VE-DALGA DESARJLAR UZERINE ETKISI

Objective: Studies on the actions of exogenous agmatine in experimental models have shown its anti-convulsant effects. However, there are no findings regarding the influence of agmatine on absence epilepsy. Therefore, we investigated the effects of the agmatine in the occurrence of spike-and-wave di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:İstanbul Tıp Fakültesi dergisi = Journal of the Istanbul Faculty of Medicine 2022-03, Vol.85 (1), p.15
Hauptverfasser: Akman, Ozlem, Utkan, Tijen, Aricioglu, Feyza, Ates, Nurbay, Karson, Ayse
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: Studies on the actions of exogenous agmatine in experimental models have shown its anti-convulsant effects. However, there are no findings regarding the influence of agmatine on absence epilepsy. Therefore, we investigated the effects of the agmatine in the occurrence of spike-and-wave discharges (SWDs) in the Wistar Albino Glaxo Rijswijk rats (WAG/Rij) model of genetic absence epilepsy. Materials and Methods: Three different doses (20, 40 or 80 mg/kg) of agmatine or saline were administered intraperito- neally to the adult WAG/Rij rats, and electroencephalography (EEG) was recorded for 2.5 hours. The number and the mean and cumulative durations of SWDs were measured. The SWD frequency characteristics were quantified by means of average power-spectra of the first 2nd segments of the SWD complexes before and after the effective dose of agmatine. Results: Agmatine, administered 80 mg/kg systemically, temporarily increased the number and cumulative duration of SWDs compared with saline injected WAG/Rij rats. This effect of agmatine, however, was not associated with any change in the frequency characteristics of the SWD complexes. There was no effect on neither the incidence nor the cumulative duration of SWDs when agmatine administered in lower doses (20 or 40 mg/kg). Conclusion: Higher doses of agmatine temporarily and slightly increase the incidence of SWDs in WAG/Rij rats, which may suggest its possible aggravating activity in absence epilepsy patients through its activity on adrenergic, serotonergic and AMPA receptors. Keywords: Agmatine, absence epilepsy, wistar albino glaxo rijswijk rats Amac: Deneysel modellerde yapilan arastirmalar ekzojen agmatinin anti-konvulzan etkilerinin oldugunu gostermistir. Ancak, agmatinin absans epilepsisi uzerindeki etkisine dair herhangi bir veri bulunmamaktadir. Bu calismada, agmatinin absans epilepsinin genetik bir modeli olan Wistar Albino Glaxo Rijswijk (WAG/Rij) irki sicanlarda Diken-ve-Dalga Desarjlar (DDD) uzerine olan etkilerini arastirdik. Gerec ve Yontem: Yetiskin WAG/Rij sicanlarda periton icine 3 farkli doz agmatin (20, 40 ya da 80 mg/kg) ya da serum fizyolojik uygulandi ve 2,5 saat boyunca elektroansefalografi (EEG) kaydedildi. Elde edilen EEG kayitlarinda DDD'lerin sayisi, ortalama ve kumulatif sureleri degerlendirildi. DDD'lerin frekans ozellikleri, etkili agmatin dozundan once ve sonra, DDD aktivitesinin ilk iki saniyelik bolumlerinin ortalama guc spektrumlari hesaplanarak karsilastirildi. Bulgul
ISSN:1305-6433
DOI:10.26650/IUITFD.904146